CEO: | Stephen O'Hara |
Finance Director: | Graham Myers |
Non-Executive Chairman: | Neil Davidson |
Research and Development Director: | Sofia Kolyda |
Non-Executive Dir: | Sean Christie |
Address: | 145-147 St John Street, London, EC1V 4PY |
Phone: | + 44 (0) 203 178 5618 |
Website: | http://www.optibiotix.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BP0RTP38 |
Currency | UK Pounds |
Share Price | 18.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 39.00 |
52 Week Low | 6.00 |
Volume | 66,018 |
Shares Issued | 97.94m |
Market Cap | £17.63m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:26 | 27,607 @ 18.11p |
14:35 | 13,359 @ 17.73p |
14:27 | 20,000 @ 17.78p |
09:32 | 338 @ 18.50p |
09:29 | 31 @ 17.50p |
CEO | Stephen O'Hara |
Finance Director | Graham Myers |
You are here: research